Federal Tipoffs Involving Delaware Newsletter for Sunday December 24, 2023 ( 4 items ) |
BLS - Mid-Atlantic Region Issues Report Entitled 'Employer-Reported Workplace Injuries and Illnesses in Delaware - 2022'
PHILADELPHIA, Pennsylvania, Dec. 20 (TNSrep) -- The U.S. Department of Labor's Bureau of Labor Statistics - Mid-Atlantic Regional Information Office issued the following report on Dec. 20, 2023, entitled "Employer-reported workplace injuries and illnesses in Delaware - 2022":
* * *
Private industry employers reported 8,300 nonfatal workplace injuries and illnesses in Delaware in 2022, the U.S. Bureau of Labor Statistics reported today. (See table A.) Regional Commissioner Alexandra Hall Bovee
more
FCC Public Safety & Homeland Security Bureau Issues Public Notice: Region 28 Regional Planning Committees 700 MHz, 800 MHz 2024 Meetings Schedule
WASHINGTON, Dec. 22 -- The Federal Communications Commission Public Safety and Homeland Security Bureau issued the following public notice (PS Docket No. 23-237; WT Docket 02-378) on Dec. 21, 2023:
* * *
The Region 28 (Delaware, Eastern Pennsylvania, and Southern New Jersey Area) Public Safety 700 MHz RPC and 800 MHz Regional Planning Committees (RPCs)/1 will hold their 2024 quarterly meetings on the following dates. All 2024 meetings will be conducted remotely via Microsoft Teams. The January
more
Justice Dept.: District Court Enjoins New York and Delaware Companies From Manufacturing and Distributing Adulterated and Misbranded Dietary Supplements
WASHINGTON, Dec. 18 -- The U.S. Department of Justice issued the following news release:
A federal court on Dec. 13 enjoined two New York companies, a Delaware company and the companies' owner from distributing and manufacturing adulterated and misbranded dietary supplements in violation of the Federal Food, Drug and Cosmetic Act (FDCA).
In a civil complaint filed on Dec. 11 in the U.S. District Court for the Eastern District of New York at the request of the U.S. Food and Drug Administration
more
N.Y. U.S. Attorney: New York and Delaware Companies are Enjoined From Manufacturing and Distributing Adulterated and Misbranded Dietary Supplements
BROOKLYN, New York, Dec. 18 -- The office of the U.S. Attorney for the Eastern District of New York issued the following news release:
Breon Peace, United States Attorney for the Eastern District of New York, Brian M. Boynton, Principal Deputy Assistant Attorney General of the Justice Department's Civil Division, and Michael C. Rogers, MS, Acting Associate Commissioner, of the U.S. Food and Drug Administration (FDA)'s Regulatory Affairs announced today that two New York companies, a Delaware co
more
|
Sign up to Receive this newsletter every day via email.